JAKAFI XR FDA approval date

The FDA approved JAKAFI XR on 1 May 2026.

FDA approval date
1 May 2026

Drug identity has not yet been verified against registry records

Also recorded as RUXOLITINIB PHOSPHATE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2026-05-01DayJAKAFI XRFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA217180", "applicant_as_listed_by_fda": "INCYTE CORP", "brand_names": ["JAKAFI XR"], "active_ingredients": ["RUXOLITINIB PHOSPHATE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20260501", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026